Carcinoma: all 6,719 studies
Page 58 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B CirrhosisCompletedNCT01357486Phase 2
- Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney CancerWithdrawnNCT01353794
- Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +AxitinibCompletedNCT01352728Phase 2
- Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cmStatus unknownNCT01351194Phase 4
- Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor ThrombosisStatus unknownNCT01350206Phase 4
- Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and DaylightStatus unknownNCT01349361Phase 2
- TheraSphere for the Treatment of Unresectable Hepatocellular CarcinomaCompletedNCT01349075
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal CarcinomaStatus unknownNCT01348256Phase 2
- Study Comparing Radiation Therapy and Chemotherapy With or Without NimotuzumabWithdrawnNCT01345084Phase 3
- MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT01344031Phase 1
- Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric CarcinomatosisSuspendedNCT01342653Phase 2
- Sorafenib in Elderly Patients With Metastatic Renal Cell CarcinomaTerminatedNCT01342627Phase 2
- Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.CompletedNCT01341535Phase 2
- Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency AblationCompletedNCT01340105Not applicable
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.CompletedNCT01339962
- Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)TerminatedNCT01337492Early Phase 1
- Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and BiomarkersStatus unknownNCT01336452Not applicable
- Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT01335074Phase 1/2
- Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell CarcinomaStatus unknownNCT01334320Not applicable
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
- Study of Axitinib in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01334112Phase 2
- Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal CarcinomaCompletedNCT01333709Phase 2
- Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01333696Phase 2
- Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic CarcinomaTerminatedNCT01333124Phase 2
- Drug-eluting Bead in Hepatocellular CarcinomaCompletedNCT01332669Phase 4
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor ThrombusCompletedNCT01328691
- Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01328223
- Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular CarcinomaWithdrawnNCT01327521Phase 3
- Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)CompletedNCT01326559Phase 2
- PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or ExtremitiesCompletedNCT01325688Phase 2
- Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment EfficiencyStatus unknownNCT01322477
- Ex Vivo Multimodal Imaging of Upper Aerodigestive EpitheliumCompletedNCT01321892
- PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)CompletedNCT01320852Not applicable
- Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary StrictureCompletedNCT01320241Phase 2
- Clinical Trial on the Prevention of Thrombocytopenia After First-line ChemotherapyTerminatedNCT01319669Phase 2/3
- Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)WithdrawnNCT01318200Phase 3
- Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)CompletedNCT01316874Phase 2/3
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423CompletedNCT01316679
- A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck CancerCompletedNCT01314755Not applicable
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular CarcinomaCompletedNCT01308723Phase 1
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)Status unknownNCT01308645Phase 2
- PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate CarcinomaCompletedNCT01304485Phase 2
- Retrospective Chart Review of ValstarCompletedNCT01304173
- A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01303237
- Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)WithdrawnNCT01301612Phase 2
- Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and NeckStatus unknownNCT01301248Phase 2
- A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis PatientsTerminatedNCT01300858Phase 1/2
- Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT01295489
- TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT01294293Phase 1
- Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin CancerCompletedNCT01292668Phase 1
- Pancreas-sparing Duodenectomy Versus Pancreatoduodenectomy for Early-stage Periampullary CarcinomaStatus unknownNCT01291927Not applicable
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic TherapyCompletedNCT01287585Phase 3
- Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective NeckCompletedNCT01287390Phase 2
- Vectibix for the Treatment of Anal CancerCompletedNCT01285778Phase 2
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCTerminatedNCT01283178Phase 1
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01283048Phase 1
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT01281852Phase 1
- Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional TherapyStatus unknownNCT01281683
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01281150Phase 1
- Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular CarcinomaStatus unknownNCT01277653
- 4SC-201 (Resminostat) in Advanced Colorectal CarcinomaCompletedNCT01277406Phase 1/2
- Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT01276496Phase 1
- Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney CancerStatus unknownNCT01274273Phase 2
- Axitinib as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01273662Phase 2
- Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial HyperplasiaStatus unknownNCT01273636
- Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II TrialStatus unknownNCT01272557Phase 2
- Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal CarcinomaCompletedNCT01271439Phase 2
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical ProtocolCompletedNCT01268878
- Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular CarcinomaStatus unknownNCT01266707Phase 1
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell CarcinomaCompletedNCT01265901Phase 3
- Caphosol in Oral Mucositis Due to Targeted TherapyCompletedNCT01265810Phase 3
- Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic MalignancyStatus unknownNCT01265472
- A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)CompletedNCT01265368Phase 1/2
- Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal CarcinomaStatus unknownNCT01265147Phase 2
- Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerCompletedNCT01264432Phase 1
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
- A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsCompletedNCT01262235Phase 1/2
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
- Fractional CO2 Laser Assisted Photodynamic TherapyCompletedNCT01260987Phase 2/3
- Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular CarcinomaCompletedNCT01259414Phase 3
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
- Novel Peptide Vaccination for Patients With Advanced Renal Cell CarcinomaCompletedNCT01254838Phase 1
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck CancerTerminatedNCT01254734Not applicable
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
- Phase 1 and 2 Study of PX-866 and CetuximabCompletedNCT01252628Phase 1/2
- Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)TerminatedNCT01252329Not applicable
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- Different Genetic Features Associated With Hepatic CarcinogenesisStatus unknownNCT01247506
- TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck TumorsTerminatedNCT01245985Phase 2
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before CystectomyTerminatedNCT01245660Early Phase 1
- Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNCT01243359Phase 1
- Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell CarcinomaStatus unknownNCT01240005Phase 1/2